Aenova Group
NDC Database

Aenova Group

NDC Database

National Drug Code (NDC) records including drug products, NDC numbers, nonproprietary names, dosage forms, strengths, labelers and marketing information.

Drug for Further Processing
  • Total Records 6
  • Latest Marketing Date 2015-08-26
  • Data Source FDA
  • First Marketing Date 1996-04-16
Company Overview

Company

Aenova Group

Country

Germany

Website

Visit Website

Email

info@aenova-group.com

Social Profiles

Company Snapshot

Aenova Group

Aenova Holding GmbH Berger Strasse 8 - 10 82319 Starnberg (Percha)

Germany

www.aenova-group.com/en info@aenova-group.com View on Map
NDC Records ( 6 records )
2012
01 May
Drug for Further Processing NDC: 65655-0003

Nonproprietary Name

isotretinoin

Dosage Form

CAPSULE, LIQUID FILLED

Strength

10 mg/1

Labeler

Swiss Caps AG

Marketing Category

DRUG FOR FURTHER PROCESSING

65655-0003

Substance

ISOTRETINOIN

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2012-05-01

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2012
01 May
Drug for Further Processing NDC: 65655-0004

Nonproprietary Name

isotretinoin

Dosage Form

CAPSULE, LIQUID FILLED

Strength

20 mg/1

Labeler

Swiss Caps AG

Marketing Category

DRUG FOR FURTHER PROCESSING

65655-0004

Substance

ISOTRETINOIN

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2012-05-01

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2015
26 Aug
Drug for Further Processing NDC: 65655-0005

Nonproprietary Name

isotretinoin

Dosage Form

CAPSULE, LIQUID FILLED

Strength

30 mg/1

Labeler

Swiss Caps AG

Marketing Category

DRUG FOR FURTHER PROCESSING

65655-0005

Substance

ISOTRETINOIN

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2015-08-26

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2012
01 May
Drug for Further Processing NDC: 65655-0006

Nonproprietary Name

isotretinoin

Dosage Form

CAPSULE, LIQUID FILLED

Strength

40 mg/1

Labeler

Swiss Caps AG

Marketing Category

DRUG FOR FURTHER PROCESSING

65655-0006

Substance

ISOTRETINOIN

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2012-05-01

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2001
29 Jun
Drug for Further Processing NDC: 65655-0013

Nonproprietary Name

miconazole nitrate

Dosage Form

SUPPOSITORY

Strength

1200 mg/1

Labeler

Swiss Caps AG

Marketing Category

DRUG FOR FURTHER PROCESSING

65655-0013

Substance

MICONAZOLE NITRATE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2001-06-29

End Marketing Date

-

Listing Record Certified Through

2026-12-31

1996
16 Apr
Drug for Further Processing NDC: 65655-0014

Nonproprietary Name

miconazole nitrate

Dosage Form

SUPPOSITORY

Strength

200 mg/1

Labeler

Swiss Caps AG

Marketing Category

DRUG FOR FURTHER PROCESSING

65655-0014

Substance

MICONAZOLE NITRATE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

1996-04-16

End Marketing Date

-

Listing Record Certified Through

2026-12-31

Related Databases
  • FDA Inspections
    27 View
  • EDQM CEP
    0 View
  • KDMF
    0 View
  • Japan DMF
    0 View
  • Eudra GMP
    0 View
  • NDC Database
    6 View
  • FDA Approved Drugs Database
    0 View
  • Drug Prices in Switzerland
    0 View
NDC Type Breakdown
6 total
  • Drug for Further Processing
Official Source

NDC data is based on publicly available National Drug Code information from the U.S. Food and Drug Administration (FDA).

Visit FDA NDC Directory
NDC Record Details Preview

Explore important National Drug Code information available in the records above.

NDC

65655-0003

Nonproprietary Name

isotretinoin

Labeler

Swiss Caps AG

Dosage Form

CAPSULE, LIQUID FILLED

FDA NDC Data

National Drug Code information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized NDC records

NDC data is based on publicly available U.S. Food and Drug Administration (FDA) National Drug Code information.

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.
Login to Submit